Skip to content

Medi3: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Medi3

BE 0628.890.986
NACE 47.741, Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€33,914
2024 · -€10,647+€44,561
Equity
€151,792
2024 · €147,878+€3,914
Cash
€44,084
2024 · €23,006+€21,077
Balance sheet total
€206,355
2024 · €175,298+€31,057

Largest movements

2024 to 2025
Assets
  • Cash +€21,077

    up €21,077 (+91.6%), from €23,006 to €44,084

    mainly Net result for the year (+€33,914) and Other debts (+€30,000)

  • Receivables within one year +€19,864

    up €19,864 (+21.5%), from €92,470 to €112,334

    of which Trade receivables: +€24,998

  • Deferred charges and accrued income -€4,591

    down €4,591 (-89.9%), from €5,105 to €513

  • Stocks and contracts -€3,909

    down €3,909 (-10.4%), from €37,591 to €33,682

  • Tangible fixed assets -€2,601

    down €2,601 (-46.4%), from €5,602 to €3,001

Equity and liabilities
  • Other debts +€30,000

    up €30,000, from €0 to €30,000

  • Trade debts -€10,097

    down €10,097 (-37.9%), from €26,657 to €16,561

  • Accrued charges and deferred income +€7,239

    up €7,239 (+951.5%), from €761 to €8,000

  • Reserves +€3,914

    up €3,914 (+3.1%), from €127,418 to €131,332

Income statement
  • Gross operating margin +€45,500

    up €45,500, from -€9,275 to €36,224

  • Taxes +€1,005

    new in 2025: €1,005

  • Financial income +€781

    up €781 (+72.1%), from €1,084 to €1,865

  • Depreciation +€718

    up €718 (+38.1%), from €1,883 to €2,601

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€10,647
Gross operating margin +€45,500
Depreciation -€718
Other operating charges -€14
Financial income +€781
Financial charges +€17
Taxes -€1,005
Result 2025 €33,914

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€51,077
Investment €0
Financing -€30,000
Cash 2024 €23,006
Net result for the year +€33,914
Depreciation +€2,601
Receivables after one year -€1,217
Stocks and contracts +€3,909
Receivables within one year -€19,864
Deferred charges and accrued income +€4,591
Trade debts -€10,097
Tax, wage and social debts +€0
Other debts +€30,000
Accrued charges and deferred income +€7,239
Contributions, distributions and other -€30,000
Cash 2025 €44,084
Every line side by side 40 lines
Line Code 2024 2025 Change %
Total assets 20/58 €175,298 €206,355 +€31,057 +17.7%
Fixed assets 21/28 €5,602 €3,001 -€2,601 -46.4%
Tangible fixed assets 22/27 €5,602 €3,001 -€2,601 -46.4%
Plant, machinery and equipment 23 €5,602 €3,001 -€2,601 -46.4%
Current assets 29/58 €169,696 €203,354 +€33,658 +19.8%
Amounts receivable after more than one year 29 €11,524 €12,740 +€1,217 +10.6%
Other amounts receivable 291 €11,524 €12,740 +€1,217 +10.6%
Stocks and contracts in progress 3 €37,591 €33,682 -€3,909 -10.4%
Stocks 30/36 €37,591 €33,682 -€3,909 -10.4%
Amounts receivable within one year 40/41 €92,470 €112,334 +€19,864 +21.5%
Trade receivables 40 €82,685 €107,683 +€24,998 +30.2%
Other amounts receivable 41 €9,785 €4,651 -€5,134 -52.5%
Cash at bank and in hand 54/58 €23,006 €44,084 +€21,077 +91.6%
Deferred charges and accrued income 490/1 €5,105 €513 -€4,591 -89.9%
Total equity and liabilities 10/49 €175,298 €206,355 +€31,057 +17.7%
Equity 10/15 €147,878 €151,792 +€3,914 +2.6%
Contributions 10/11 €20,460 €20,460 = 0.0%
Reserves 13 €127,418 €131,332 +€3,914 +3.1%
Distributable reserves 133 €127,418 €131,332 +€3,914 +3.1%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €27,420 €54,563 +€27,143 +99.0%
Amounts payable within one year 42/48 €26,659 €46,563 +€19,904 +74.7%
Trade debts 44 €26,657 €16,561 -€10,097 -37.9%
Suppliers 440/4 €26,657 €16,561 -€10,097 -37.9%
Taxes, remuneration and social security 45 €2 €3 +€0 +20.9%
Taxes 450/3 €2 €3 +€0 +20.9%
Other amounts payable 47/48 €0 €30,000 +€30,000
Accrued charges and deferred income 492/3 €761 €8,000 +€7,239 +951.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,883 €2,601 +€718 +38.1%
Other operating charges 640/8 €505 €520 +€14 +2.8%
Gross operating margin 9900 -€9,275 €36,224 +€45,500
Operating profit (loss) 9901 -€11,663 €33,103 +€44,767
Financial income 75/76B €1,084 €1,865 +€781 +72.1%
Recurring financial income 75 €1,084 €1,865 +€781 +72.1%
Financial charges 65/66B €68 €50 -€17 -25.8%
Recurring financial charges 65 €68 €50 -€17 -25.8%
Profit (loss) for the period before taxes 9903 -€10,647 €34,918 +€45,565
Income taxes 67/77 - €1,005 +€1,005
Profit (loss) for the period 9904 -€10,647 €33,914 +€44,561
Profit (loss) for the period to be appropriated 9905 -€10,647 €33,914 +€44,561

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.